Related Experiment Video
Updated: May 11, 2026
12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
Assessing patients' information needs regarding drug-drug interactions
Alex Mutebi1, Terri L Warholak, Lisa E Hines
1College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA. mutebi@pharmacy.arizona.edu
Summary
Patients need clear information on drug-drug interactions (DDIs), including their seriousness and effects on health conditions. Education should cover identifying, minimizing, and managing potential harm from DDIs.
Area of Science:
- Pharmacology
- Patient Education
- Health Informatics
Background:
- Drug-drug interactions (DDIs) pose significant risks to patient safety.
- Effective patient education is crucial for managing medication-related risks.
- Understanding patient information needs is key to developing targeted educational resources.
Purpose of the Study:
- To assess patient information needs concerning drug-drug interactions (DDIs).
- To inform the development of patient-centered DDI education resources.
- To identify key areas of concern for patients regarding medication interactions.
Main Methods:
- A cross-sectional study was conducted using an online questionnaire.
- 100 registered users of an online medication monitoring service (MediGuard) in the United States participated.
- The study assessed participants' information needs and the perceived importance of questions related to DDI detection and prevention.
Main Results:
- Participants frequently expressed concerns about identifying interacting medications, the seriousness of DDIs, and interactions with over-the-counter (OTC) drugs and foods.
- Key concerns included exacerbating comorbidities, adverse effects, and methods to minimize harm.
- Significant differences in the importance of DDI questions were noted based on gender, number of prescription, and OTC medications (P < 0.05).
Conclusions:
- Patient education on DDIs should prioritize the seriousness of interactions and their impact on comorbidities.
- Information on interactions with OTC medications and foods is essential.
- Educational programs must address methods for identifying, minimizing, and managing DDIs effectively.
Related Concept Videos
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...